PH27257A - Therapeutically active chloro substituted benzimidazole - Google Patents

Therapeutically active chloro substituted benzimidazole

Info

Publication number
PH27257A
PH27257A PH39730A PH39730A PH27257A PH 27257 A PH27257 A PH 27257A PH 39730 A PH39730 A PH 39730A PH 39730 A PH39730 A PH 39730A PH 27257 A PH27257 A PH 27257A
Authority
PH
Philippines
Prior art keywords
therapeutically active
substituted benzimidazole
chloro substituted
active chloro
benzimidazole
Prior art date
Application number
PH39730A
Other languages
English (en)
Inventor
Arne Elof Brandstrom
Carl I Starke
Gunnel Elizabeth Sunden
Per Lennart Lindberg
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of PH27257A publication Critical patent/PH27257A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
PH39730A 1988-12-22 1989-12-19 Therapeutically active chloro substituted benzimidazole PH27257A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19888804628A SE8804628D0 (sv) 1988-12-22 1988-12-22 New compounds

Publications (1)

Publication Number Publication Date
PH27257A true PH27257A (en) 1993-05-04

Family

ID=20374309

Family Applications (1)

Application Number Title Priority Date Filing Date
PH39730A PH27257A (en) 1988-12-22 1989-12-19 Therapeutically active chloro substituted benzimidazole

Country Status (26)

Country Link
US (1) US5019584A (zh)
EP (1) EP0451188B1 (zh)
JP (1) JP2793907B2 (zh)
CN (1) CN1028232C (zh)
AT (1) ATE110379T1 (zh)
AU (1) AU636866B2 (zh)
CA (1) CA2005987C (zh)
DD (1) DD296077A5 (zh)
DE (1) DE68917738T2 (zh)
DK (1) DK170801B1 (zh)
FI (1) FI913036A0 (zh)
GR (1) GR1000318B (zh)
HU (1) HUT57203A (zh)
IE (1) IE64850B1 (zh)
IL (1) IL92797A (zh)
LT (1) LT3981B (zh)
LV (1) LV10268B (zh)
NO (1) NO178338C (zh)
PH (1) PH27257A (zh)
PT (1) PT92647B (zh)
RO (1) RO110496B1 (zh)
RU (1) RU2070199C1 (zh)
SE (1) SE8804628D0 (zh)
WO (1) WO1990006926A1 (zh)
YU (1) YU242589A (zh)
ZA (1) ZA899796B (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2083606C (en) * 1990-06-20 2001-08-21 Arne Elof Brandstrom Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
NZ244301A (en) * 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
US6016044A (en) * 1995-09-11 2000-01-18 Alaris Medical Systems, Inc. Open-loop step motor control system
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
JP2005521662A (ja) * 2002-01-25 2005-07-21 サンタラス インコーポレイティッド プロトンポンプ阻害剤の経粘膜送達
AU2003224781A1 (en) * 2002-03-26 2003-10-13 Dr. Reddy's Laboratories Limited Crystalline forms of rabeprazole sodium
JP2006518751A (ja) * 2003-02-20 2006-08-17 サンタラス インコーポレイティッド 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物
US20050031700A1 (en) * 2003-07-18 2005-02-10 Sanatarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2531564C (en) * 2003-07-18 2016-01-19 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (zh) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
US4331671A (en) * 1981-01-09 1982-05-25 Sterling Drug Inc. 5-(Pyridinyl)-1H-benzimidazoles and 1-hydroxy-6-(pyridinyl)-1H-benzimidazoles and their cardiotonic use
IL71664A (en) 1983-05-03 1987-11-30 Byk Gulden Lomberg Chem Fab Fluoroalkoxy compounds,process for their preparation and pharmaceutical compositions containing the same
JPS6150979A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
SE8500996D0 (sv) * 1985-03-01 1985-03-01 Haessle Ab Method of treatment
US4738975A (en) * 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
GB8610607D0 (en) * 1986-04-30 1986-06-04 Smith Kline French Lab Chemical compounds
FR2593178B1 (fr) * 1986-01-20 1988-04-29 Esteve Labor Dr Derives de 2-benzimidazolylalkylthio (ou sulfinyle ou sulfonyle) leur preparation et leur application en tant que medicaments.
WO1989003830A1 (en) * 1987-10-30 1989-05-05 Aktiebolaget Hässle 2-pyridinylmethyl (sulfinyl or thio)benzimidazoles for treatment of diseases related to bone loss

Also Published As

Publication number Publication date
DE68917738D1 (de) 1994-09-29
CN1043714A (zh) 1990-07-11
NO178338B (no) 1995-11-27
AU636866B2 (en) 1993-05-13
WO1990006926A1 (en) 1990-06-28
DE68917738T2 (de) 1994-12-22
CN1028232C (zh) 1995-04-19
JPH04502462A (ja) 1992-05-07
HU901085D0 (en) 1991-09-30
AU4817690A (en) 1990-07-10
ATE110379T1 (de) 1994-09-15
YU242589A (en) 1991-04-30
FI913036A0 (fi) 1991-06-20
IL92797A (en) 1994-12-29
DK122391A (da) 1991-06-24
SE8804628D0 (sv) 1988-12-22
GR1000318B (el) 1992-06-25
LTIP1722A (en) 1995-07-25
JP2793907B2 (ja) 1998-09-03
IE894049L (en) 1990-06-22
CA2005987A1 (en) 1990-06-22
DD296077A5 (de) 1991-11-21
PT92647A (pt) 1990-06-29
RU2070199C1 (ru) 1996-12-10
IL92797A0 (en) 1990-09-17
ZA899796B (en) 1990-08-29
EP0451188B1 (en) 1994-08-24
CA2005987C (en) 1999-04-13
DK170801B1 (da) 1996-01-22
LV10268B (en) 1995-02-20
LV10268A (lv) 1994-10-20
LT3981B (en) 1996-06-25
NO912416D0 (no) 1991-06-20
IE64850B1 (en) 1995-09-06
PT92647B (pt) 1995-09-12
GR890100834A (en) 1991-03-15
DK122391D0 (da) 1991-06-21
RO110496B1 (ro) 1996-01-30
NO178338C (no) 1996-03-06
HUT57203A (en) 1991-11-28
SE8804628A (zh) 1988-12-22
NO912416L (no) 1991-07-31
US5019584A (en) 1991-05-28
EP0451188A1 (en) 1991-10-16

Similar Documents

Publication Publication Date Title
SE8804629A (zh)
PH27257A (en) Therapeutically active chloro substituted benzimidazole
PH27446A (en) Compound with gastric acid inhibitory effect
JO1653B1 (en) The current benzimidazole is a therapeutically active method for preparing it
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)
ITMI913248A1 (it) Composizioni terapeutiche adatte per la somministrazione orale contenenti come principio attivo uno o piu' tioesteri del glutatione e procedimento per la preparazione dei suddetti principi attivi